Phase 1/2 Study of UI-102 in Selected Advanced Cancers

Clinical trial NCT07605962 · RECRUITING

Trial details

NCT number: NCT07605962
Sponsor: United Immunity, co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2026-05-20
Primary completion: 2030-03-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.